CEUFX | LMGTX | CEUFX / LMGTX | |
Total Expense Ratio | 0.91 | 1.80 | 51% |
Annual Report Gross Expense Ratio | 0.91 | 1.80 | 51% |
Fund Existence | 23 years | 30 years | - |
Gain YTD | 15.829 | 16.762 | 94% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 250 | 1000 | 25% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 133B | 7B | 1,899% |
Annual Yield % from dividends | 0.81 | 0.47 | 173% |
Returns for 1 year | 8.72 | 11.76 | 74% |
Returns for 3 years | 37.34 | 49.84 | 75% |
Returns for 5 years | 13.84 | 28.89 | 48% |
Returns for 10 years | 52.27 | 112.71 | 46% |
1 Day | |||
---|---|---|---|
STOCK / NAME | Price $ | Chg $ | Chg % |
ADCT | 3.54 | 0.14 | +4.12% |
ADC Therapeutics SA | |||
CDLR | 20.97 | 0.56 | +2.74% |
Cadeler A/S American Depositary Share (each representing four (4) | |||
ACGLN | 18.08 | 0.19 | +1.06% |
Arch Capital Group Ltd | |||
GROV | 1.53 | -0.01 | -0.65% |
Grove Collaborative Holdings | |||
BIRK | 50.19 | -0.43 | -0.85% |
Birkenstock Holding plc |